Keyphrases
Thymidylate Synthase
100%
Adrenocortical Cancer
100%
Topoisomerase IIα
100%
Mitotane
60%
Adrenocortical Carcinoma
40%
Adriamycin
40%
Etoposide
40%
Tumor
30%
Cisplatin
30%
Doxorubicin
30%
Alpha Expressions
30%
Immunohistochemistry
20%
Time to Progression
20%
Non-associated
10%
Multivariate Analysis
10%
Protein Expression
10%
Disease-free Survival
10%
Overall Survival
10%
Prognostic Factors
10%
Topoisomerase Inhibitors
10%
MRNA Expression
10%
Clinical Data
10%
Metastatic Disease
10%
Disease Response
10%
Anthracyclines
10%
Disease Stabilization
10%
Predictive Role
10%
Efficacy Predictor
10%
Medicine and Dentistry
Malignant Neoplasm
100%
Thymidylate Synthase
100%
DNA Topoisomerase (ATP Hydrolysing)
100%
Doxorubicin
70%
Mitotane
60%
Adrenal Cortex Carcinoma
40%
Etoposide
40%
Neoplasm
30%
Cisplatin
30%
Immunohistochemistry
20%
Messenger RNA
20%
Diseases
20%
Disease Free Survival
10%
Overall Survival
10%
Protein Expression
10%
Metastatic Carcinoma
10%
Multivariate Analysis
10%
Anthracycline
10%
Topoisomerase Inhibitor
10%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Thymidylate Synthase
100%
DNA Topoisomerase (ATP Hydrolysing)
100%
Doxorubicin
70%
Mitotane
60%
Etoposide
40%
Adrenal Cortex Carcinoma
40%
Neoplasm
30%
Cisplatin
30%
Messenger RNA
20%
Diseases
20%
Overall Survival
10%
Disease Free Survival
10%
Metastasis
10%
Anthracycline
10%
DNA Topoisomerase Inhibitor
10%
Biochemistry, Genetics and Molecular Biology
DNA Gyrase
100%
Thymidylate Synthase
100%
Doxorubicin
70%
Cisplatin
30%
Messenger RNA
20%
DNA Topoisomerase
10%
Topoisomerase
10%
Protein Expression
10%
Disease Free Survival
10%
Overall Survival
10%
Multivariate Analysis
10%
Anthracycline
10%